Exchange Capital Management’s AbbVie ABBV Stock Holding History

Exchange Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$319K	Buy	1,716 +26	+2%	+$4.83K	0.05%	185
2025 Q1	$354K	Buy	1,690 +103	+6%	+$20K	0.06%	182
2024 Q4	$282K	Buy	+1,587	New	+$292K	0.04%	195
2021 Q1	–	Sell	-1,950	Closed	-$209K	–	163
2020 Q4	$209K	Buy	+1,950	New	+$187K	0.05%	156
2018 Q4	–	Sell	-58	Closed	-$5K	–	133
2018 Q3	$5K	Buy	+58	New	+$5.5K	﹤0.01%	259
2016 Q3	–	Sell	-75	Closed	-$5K	–	222
2016 Q2	$5K	Buy	+75	New	+$4.57K	﹤0.01%	203
2015 Q1	–	Sell	-134	Closed	-$9K	–	85
2014 Q4	$9K	Buy	+134	New	+$8.45K	﹤0.01%	174

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Exchange Capital Management's ABBV Position: Q2 2025 in Review

Exchange Capital Management increased its AbbVie (ABBV) stake by 1.5% in Q2 2025, buying an estimated $4.83K and bringing the position to 1,716 shares worth $319K. The position accounts for 0.05% of the portfolio, ranked #185.

Exchange Capital Management first reported a position in ABBV in Q4 2014 and has held it in 7 quarters since. The position peaked at $354K in Q1 2025. 3,787 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Exchange Capital Management held 1,716 shares of AbbVie worth $319K as of Q2 2025.
Exchange Capital Management bought 26 AbbVie shares in Q2 2025, an estimated $4.83K.
AbbVie made up 0.05% of Exchange Capital Management's portfolio in Q2 2025, its #185 holding.
Exchange Capital Management first reported a position in AbbVie in Q4 2014 and has held it in 7 quarters since.
Exchange Capital Management's AbbVie position peaked at $354K in Q1 2025.
3,787 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Exchange Capital Management's 13F filing for Q2 2025, filed 21 Jul 2025.